secwatch.observer — SEC 8-K summary
======================================

Issuer:     ANAPTYSBIO, INC (ANAB)
CIK:        0001370053
Form:       8-K
Filed at:   2026-05-29T20:15:16+00:00
Accession:  0001193125-26-248326
Event type: other_material
Sentiment:  neutral
Materiality: 0.10
Item codes: 7.01
LLM model:  deepseek-v4-flash:cloud@v2

AnaptysBio files Form 8937 with IRS regarding tax treatment of First Tracks spin-off dividend
--------------------------------------------------------------------------------

- Filed Form 8937 with IRS concerning dividend from separation and spin-off of First Tracks Biotherapeutics.
- Form 8937 provides guidance on how the dividend is treated by stockholders and change in tax basis.
- Form 8937 information will be posted on AnaptysBio's website under the Investors section.
- Company urges stockholders to consult their own tax advisor regarding tax consequences of the distribution.
- This update is for informational purposes only and not to be considered legal or tax advice.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1370053/000119312526248326/0001193125-26-248326-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1370053/000119312526248326/anab-20260529.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-248326

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer